GPCR Live signaler | Maksimer profitt med Getagraph.com

KJøP 120835 min ago

@ $46.21

Utstedt: 14 feb 2024 @ 18:06

Avkastning: -14.01%

Forrige signal: feb 14 - 15:30

Forrige signal: Selg

Avkastning: -4.71 %

Live Chart Being Loaded With Signals

Commentary (8 mai 2024 @ 16:59):

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs...

Stats
Dagens volum	32 307.00
Gjennomsnittsvolum	594 275
Markedsverdi	1.85B
EPS	$-0.620 ( 2023-11-14 )
Neste inntjeningsdato	( $-0.210 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-16.35
ATR14	$0.160 (0.40%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-17	Fmr Llc	Buy	0
2024-03-15	Lin Xichen	Buy	213 486	Stock Option (right to buy)
2024-03-15	Bach Mark Allen	Buy	65 352	Stock Option (right to buy)
2024-03-15	Ma Yingli	Buy	91 494	Stock Option (right to buy)
2024-03-15	Yoon Jun	Buy	148 134	Stock Option (right to buy)

INSIDER POWER
30.57
Last 43 transactions
Buy: 9 065 015 \| Sell: 6 065 489

Structure Therapeutics Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Structure Therapeutics Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-949 174 (0.00 %)
EPS:	$-2.44

FY	2023
Omsetning:	$0
Bruttogevinst:	$-949 174 (0.00 %)
EPS:	$-2.44

FY	2022
Omsetning:	$0
Bruttogevinst:	$-623 258 (0.00 %)
EPS:	$-1.400

Financial Reports:

No articles found.

Structure Therapeutics

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.

Sanntidsoppdatering for Structure Therapeutics [GPCR]

Upcoming Earnings Alert